Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause.
about
Clinical epidemiology of premenstrual disorder: informing optimized patient outcomesThe Tissue-Selective Estrogen Complex: A Review of Current EvidenceConjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.Biological agents in management of osteoporosis.Efficacy of desvenlafaxine succinate for menopausal hot flashes.
P2860
Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Bazedoxifene + conjugated estr ...... associated with the menopause.
@en
type
label
Bazedoxifene + conjugated estr ...... associated with the menopause.
@en
prefLabel
Bazedoxifene + conjugated estr ...... associated with the menopause.
@en
P2860
P1476
Bazedoxifene + conjugated estr ...... associated with the menopause.
@en
P2093
John Christopher Gallagher
Sri Harsha Tella
P2860
P304
P356
10.1517/14656566.2013.844790
P407
P577
2013-10-07T00:00:00Z